Beijing Leadman Biochemistry Co Ltd
Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more
Beijing Leadman Biochemistry Co Ltd (300289) - Total Liabilities
Latest total liabilities as of September 2025: CN¥96.51 Million CNY
Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has total liabilities worth CN¥96.51 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Leadman Biochemistry Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Beijing Leadman Biochemistry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Beijing Leadman Biochemistry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Energiekontor AG
F:EKT
|
Germany | €683.30 Million |
|
Ranger Energy Services Inc
NYSE:RNGR
|
USA | $102.80 Million |
|
Abacus Group
AU:ABG
|
Australia | AU$1.03 Billion |
|
Korea Line
KO:005880
|
Korea | ₩1.77 Trillion |
|
FocalTech Systems Co Ltd
TW:3545
|
Taiwan | NT$4.92 Billion |
|
Everjoy Health Group Co Ltd
SHE:002162
|
China | CN¥1.17 Billion |
|
Allied Blenders & Distillers Ltd
NSE:ABDL
|
India | ₹19.72 Billion |
|
Samhyun
KQ:437730
|
Korea | ₩32.92 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Beijing Leadman Biochemistry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 15.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Leadman Biochemistry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Leadman Biochemistry Co Ltd (2008–2024)
The table below shows the annual total liabilities of Beijing Leadman Biochemistry Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥103.84 Million | -22.37% |
| 2023-12-31 | CN¥133.77 Million | -38.26% |
| 2022-12-31 | CN¥216.67 Million | -41.49% |
| 2021-12-31 | CN¥370.30 Million | +48.17% |
| 2020-12-31 | CN¥249.92 Million | -5.39% |
| 2019-12-31 | CN¥264.18 Million | -9.47% |
| 2018-12-31 | CN¥291.80 Million | -11.23% |
| 2017-12-31 | CN¥328.73 Million | +0.80% |
| 2016-12-31 | CN¥326.13 Million | -18.21% |
| 2015-12-31 | CN¥398.76 Million | -23.82% |
| 2014-12-31 | CN¥523.48 Million | +33.25% |
| 2013-12-31 | CN¥392.86 Million | +6.42% |
| 2012-12-31 | CN¥369.17 Million | +154.80% |
| 2011-12-31 | CN¥144.89 Million | +46.36% |
| 2010-12-31 | CN¥98.99 Million | +107.62% |
| 2009-12-31 | CN¥47.68 Million | +58.91% |
| 2008-12-31 | CN¥30.01 Million | -- |